Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #48,201 to #48,250.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Aneurysm epidemiology and demographics (3 revisions)
  2. Aneurysm future or investigational therapies (3 revisions)
  3. Aneurysm laboratory findings (3 revisions)
  4. Aneurysm other diagnostic studies (3 revisions)
  5. Aneurysm other imaging findings (3 revisions)
  6. Aneurysmal disease (3 revisions)
  7. Angina bullosa haemorrhagica (3 revisions)
  8. Angioedema CT (3 revisions)
  9. Angioedema MRI (3 revisions)
  10. Angioedema ultrasound (3 revisions)
  11. Angioimmunoblastic T-cell lymphoma biopsy (3 revisions)
  12. Angioimmunoblastic T-cell lymphoma case study one (3 revisions)
  13. Angioimmunoblastic T-cell lymphoma cost-effectiveness of therapy (3 revisions)
  14. Angioimmunoblastic T-cell lymphoma electrocardiogram (3 revisions)
  15. Angioimmunoblastic T-cell lymphoma future or investigational therapies (3 revisions)
  16. Angioimmunoblastic T-cell lymphoma laboratory findings (3 revisions)
  17. Angioimmunoblastic T-cell lymphoma primary prevention (3 revisions)
  18. Angioimmunoblastic T-cell lymphoma staging (3 revisions)
  19. Angioma chest x ray (3 revisions)
  20. Angioma echocardiography or ultrasound (3 revisions)
  21. Angioma historical perspective (3 revisions)
  22. Angioma laboratory studies (3 revisions)
  23. Angioma staging (3 revisions)
  24. Angiomatosis (3 revisions)
  25. Angiomyolipoma case study one (3 revisions)
  26. Angiomyolipoma cost-effectiveness of therapy (3 revisions)
  27. Angiomyolipoma secondary prevention (3 revisions)
  28. Angiopathy (3 revisions)
  29. Angiopoietin-related protein 2 (3 revisions)
  30. Angiopoietin receptor (3 revisions)
  31. Angiostrongyliasis medical therapy (3 revisions)
  32. Angiostrongyliasis primary prevention (3 revisions)
  33. Angiotensin Converting Enzyme Inhibitor (patient information) (3 revisions)
  34. Angiotensin II receptor antagonist (3 revisions)
  35. Angiotensin II receptor type 1 (3 revisions)
  36. Anhedonia primary prevention (3 revisions)
  37. Anidulafungin clinical pharmacology (3 revisions)
  38. Anidulafungin overdosage (3 revisions)
  39. Anileridine (3 revisions)
  40. Anise (3 revisions)
  41. Ankylosing spondylitis primary prevention (3 revisions)
  42. Ankyrin (3 revisions)
  43. Ann Arbor staging (3 revisions)
  44. Annexin A5 (3 revisions)
  45. Annuloaortic ectasia (3 revisions)
  46. Annuloplasty (3 revisions)
  47. Anonychia (3 revisions)
  48. Anophthalmia-short stature-obesity (3 revisions)
  49. Anorexia nervosa other imaging findings (3 revisions)
  50. Anorexia nervosa secondary prevention (3 revisions)

View ( | ) (20 | 50 | 100 | 250 | 500)